MHRAsafety guidance72% confidence
Field Safety Notices: 8 -12 June 2026
Source: MHRA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (ild) as Amgen.
Regulatory Analysis
List of Field Safety Notices for 8-12 June 2026
Supporting Context
- Therapeutic area
- Respiratory · Asthma
- Sub-indication
- Ild
Related signal: Amgen's AMG 691 Phase 1 Study Targets Safety in Asthma Patients